These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7872882)

  • 1. Migraine prophylaxis with divalproex.
    Mathew NT; Saper JR; Silberstein SD; Rankin L; Markley HG; Solomon S; Rapoport AM; Silber CJ; Deaton RL
    Arch Neurol; 1995 Mar; 52(3):281-6. PubMed ID: 7872882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
    Kaniecki RG
    Arch Neurol; 1997 Sep; 54(9):1141-5. PubMed ID: 9311358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
    Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
    Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group.
    Silberstein SD; Collins SD
    Headache; 1999 Oct; 39(9):633-43. PubMed ID: 11284461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
    Caruso JM; Brown WD; Exil G; Gascon GG
    Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium in headache: literature review and clinical guidelines.
    Silberstein SD
    Headache; 1996 Oct; 36(9):547-55. PubMed ID: 8916563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
    Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
    Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM; Schim JD; Chippendale TJ
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of gabapentin in migraine prophylaxis.
    Mathew NT; Rapoport A; Saper J; Magnus L; Klapper J; Ramadan N; Stacey B; Tepper S
    Headache; 2001 Feb; 41(2):119-28. PubMed ID: 11251695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
    Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
    Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
    Jensen R; Brinck T; Olesen J
    Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.